| Tiffany A Beam, OT | |
|
2626 Wesleyan Dr, Belleville, KS 66935-2440 | |
| (785) 527-5636 | |
| Not Available |
| Full Name | Tiffany A Beam |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 2626 Wesleyan Dr, Belleville, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437322336 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 1702264 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tiffany A Beam, OT 2222 Sullivan Trl, Easton, PA 18040-7958 Ph: () - | Tiffany A Beam, OT 2626 Wesleyan Dr, Belleville, KS 66935-2440 Ph: (785) 527-5636 |
News Archive
Tissue Regeneration Systems, Inc. today announced that it has received 510K approval from the U.S. Food and Drug Administration for its Cranial Bone Void Filler product, indicated for use in the repair of neurosurgical burr holes.
Increased incidence of gastroesophageal reflux symptoms (GERS) reported by a large population of 9/11 World Trade Center attack survivors, most of whom had not reported any GERD-related symptoms prior to 9/11, worsened the health-related quality life for many rescue and recovery workers, lower-Manhattan residents and local workers who were exposed to the dust cloud and other contaminants in the aftermath of 9/11, according to a study published online today online today in The American Journal of Gastroenterology.
The Hamilton Project, an initiative at the Brookings Institution, hosted a forum, "Health Care Reconsidered: Options for Change," today at the Brookings Institution in Washington, D.C. At the event, policy papers on reforming Medicare Part "D" (including closing the "donut hole" gap in prescription drug coverage), improving preventive care and promoting greater affordability through progressive cost-sharing were released by The Hamilton Project.
Many including Queensland MP Rob Messenger, feel that the seven year sentence awarded to Dr. Jayant Patel by the Brisbane's Supreme Court yesterday is "grossly inadequate." Patel was being tried for three cases of manslaughter and one case of grievous bodily injury during his tenure as Director of Surgery at Bundaberg Base hospital between 2003 and 2005.
ImmunoCellular Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has given clearance to a physician sponsored investigative new drug (IND) application to initiate a Phase I clinical trial of ICT-121, IMUC's novel dendritic-cell-based vaccine targeting CD-133, an antigen that is highly expressed by multiple solid tumors.
› Verified 7 days ago
Brenna Meyer, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2626 Wesleyan Dr, Belleville, KS 66935 Phone: 785-527-5636 |